| Added: COMPONENTS REFERENCE INTERVAL |
| Added: Lead, Whole Blood < 6 years: <3.5 µg/dL |
| Added: Lead, Whole Blood >= 6 years: <5.0 µg/dL |
| Added: Zinc Protoporphyrin (ZPP) |
| Added: Whole Blood: 0 - 69 µmol/mol heme |
| Added: Zinc Protoporphyrin (ZPP) |
| Added: Whole Blood: 0 - 40 µg/dL |
| Added: These results should be interpreted in the context of OSHA, CDC, and local and state occupational health requirements. |
| Added: Additional information is available through the following |
| Deleted: | Added: link: |
| Added: https://www.cdc.gov/niosh/topics/ables/description.html |
| Added: For occupational exposure to lead, OSHA requires ZPP whole blood concentration to be reported in units of ug/dL. For adults, conversion of ZPP to units of ug/dL assumes a hemoglobin level of 15 g/dL. Methodology used in lead analysis is atomic absorption. Methodology used for ZPP is Protofluor Z system manufactured by Helena Laboratories. This test has been modified from the |
| Added: manufacturer's instructions. Elevated results may be due to skin or collection-related |
| Added: contamination, including the use of a noncertified lead-free tube, or transfer of sample into a noncertified lead-free tube. If contamination concerns exist due to elevated levels of blood lead, confirmation with a venous specimen collected in a certified lead-free tube is recommended. The Blood Lead test was developed and the performance characteristics determined by Warde Medical Laboratory. It has not been cleared or approved by the FDA. The laboratory is regulated under CLIA as qualified to perform high-complexity testing. This test is used for patient testing purposes. It should not be regarded as investigational or for research. |
